Evidence map›Paper›PMID 19706284›Full record

ArticleArchives of biochemistry and biophysics2009

PMA induces expression from the herpes simplex virus thymidine kinase promoter via the activation of JNK and ERK in the presence of adenoviral E1A proteins.

Amde Selassie Shifera, John A Hardin

Open access · greenAbstract read
In one paragraph

Article in Archives of biochemistry and biophysics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Amde Selassie ShiferaDepartment of Internal Medicine, Albert Einstein College of Medicine, Bronx, NY, USA. shiferaa@vision.ucsf.edu
John A Hardin
Albert Einstein College of Medicine · USYeshiva University · US

Funding

RHEUMATOLOGY TRAINING GRANTT32AR050947 · NIAMS · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI HARDIN, JOHN A. · 2004 to 2008
$745k
NIAMS NIH HHS T32 AR050947
6 · The paper itself

Abstract

The herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) promoter contains elements involved in both constitutive and induced expression. We determined that phorbol 12-myristate 13-acetate (PMA) induces the HSV-1 TK promoter in HEK293 cells. However, PMA did not induce expression from the promoter in HeLa cells and did not result in a globally increased gene expression in HEK293 cells. Induction of HSV-1 TK promoter required activation of both of JNK and ERK pathways. However, activation of the two pathways alone was not sufficient for induction of HSV-1 TK promoter. By transiently transfecting into HeLa cells the adenoviral E1A gene, which exists as an integrant in HEK293 genome, we demonstrated that E1A proteins are necessary for induction of HSV-1 TK promoter by PMA. We propose mechanisms by which signaling pathways activated by the tumor-promoter PMA cooperate with the oncogene E1A to stimulate a eukaryotic promoter, namely the HSV-1 TK promoter.

Indexed as

Adenovirus E1A ProteinsBase SequenceCell LineDNA PrimersEnzyme ActivationGene ExpressionGenes, ReporterGenes, ViralHeLa CellsHerpesvirus 1, HumanHumansJNK Mitogen-Activated Protein KinasesLuciferases, RenillaMAP Kinase Signaling SystemMitogen-Activated Protein Kinase KinasesModels, BiologicalAdenovirus E1A ProteinsDNA PrimersJNK Mitogen-Activated Protein KinasesLuciferases, RenillaMitogen-Activated Protein Kinase KinasesRNA, MessengerTetradecanoylphorbol AcetateThymidine Kinase

Identifiers

PMID19706284
PMCPMC2763905
OpenAlexW2019363654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.